BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26322673)

  • 1. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.
    Kapambwe S; Sahasrabuddhe VV; Blevins M; Mwanahamuntu MH; Mudenda V; Shepherd BE; Chibwesha CJ; Pfaendler KS; Hicks ML; Vermund SH; Stringer JS; Parham GP
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e20-6. PubMed ID: 26322673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.
    Mwanahamuntu MH; Sahasrabuddhe VV; Blevins M; Kapambwe S; Shepherd BE; Chibwesha C; Pfaendler KS; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Stringer JS; Parham GP
    PLoS One; 2013; 8(9):e74607. PubMed ID: 24058599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
    Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
    Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia.
    Parham GP; Mwanahamuntu MH; Kapambwe S; Muwonge R; Bateman AC; Blevins M; Chibwesha CJ; Pfaendler KS; Mudenda V; Shibemba AL; Chisele S; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Chi BH; Stringer JS; Sankaranarayanan R; Sahasrabuddhe VV
    PLoS One; 2015; 10(4):e0122169. PubMed ID: 25885821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HIV infection on invasive cervical cancer in Kenyan women.
    Gichangi PB; Bwayo J; Estambale B; De Vuyst H; Ojwang S; Rogo K; Abwao H; Temmerman M
    AIDS; 2003 Sep; 17(13):1963-8. PubMed ID: 12960829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening outcomes in Zambia, 2010-19: a cohort study.
    Pry JM; Manasyan A; Kapambwe S; Taghavi K; Duran-Frigola M; Mwanahamuntu M; Sikazwe I; Matambo J; Mubita J; Lishimpi K; Malama K; Bolton Moore C
    Lancet Glob Health; 2021 Jun; 9(6):e832-e840. PubMed ID: 34019837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher educational attainment associated with reduced likelihood of abnormal cervical lesions among Zambian women - a cross sectional study.
    Hamoonga TE; Likwa RN; Musonda P; Michelo C
    BMC Cancer; 2017 Oct; 17(1):681. PubMed ID: 29029626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya.
    Maggwa BN; Hunter DJ; Mbugua S; Tukei P; Mati JK
    AIDS; 1993 May; 7(5):733-8. PubMed ID: 8318180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of HIV status on non-metastatic cervical cancer progression among patients in Lusaka, Zambia.
    Trejo MJ; Lishimpi K; Kalima M; Mwaba CK; Banda L; Chuba A; Chama E; Msadabwe SC; Bell ML; Harris RB; Jacobs E; Soliman A
    Int J Gynecol Cancer; 2020 May; 30(5):613-618. PubMed ID: 32200353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HIV infection on metastatic cervical cancer and age at diagnosis among patients in Lusaka, Zambia.
    Trejo MJ; Soliman AS; Chen Y; Kalima M; Chuba A; Chama E; Mwaba CK; Banda L; Lishimpi K
    Int J Gynaecol Obstet; 2022 Mar; 156(3):521-528. PubMed ID: 34121186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, Predictors, and Same Day Treatment of Positive VIA Enhanced by Digital Cervicography and Histopathology Results in a Cervical Cancer Prevention Program in Cameroon.
    DeGregorio GA; Bradford LS; Manga S; Tih PM; Wamai R; Ogembo R; Sando Z; Liu Y; Schwaiger C; Rao SR; Kalmakis K; Kennedy Sheldon L; Nulah K; Welty E; Welty T; Ogembo JG
    PLoS One; 2016; 11(6):e0157319. PubMed ID: 27280882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer incidence after up to 20 years of observation among women with HIV.
    Massad LS; Hessol NA; Darragh TM; Minkoff H; Colie C; Wright RL; Cohen M; Seaberg EC
    Int J Cancer; 2017 Oct; 141(8):1561-1565. PubMed ID: 28670714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of HIV testing among women diagnosed with invasive cervical cancer in the New Jersey Medicaid Program.
    McGee-Avila JK; Doose M; Nova J; Kumar R; Stroup AM; Tsui J
    Cancer Causes Control; 2020 Oct; 31(10):931-941. PubMed ID: 32803402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study.
    Grabar S; Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; Pradier C; Salmon D; Simon A; Pourcher V; Spano JP; Poizot-Martin I; Costagliola D
    HIV Med; 2019 Mar; 20(3):222-229. PubMed ID: 30693646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
    Abraham AG; D'Souza G; Jing Y; Gange SJ; Sterling TR; Silverberg MJ; Saag MS; Rourke SB; Rachlis A; Napravnik S; Moore RD; Klein MB; Kitahata MM; Kirk GD; Hogg RS; Hessol NA; Goedert JJ; Gill MJ; Gebo KA; Eron JJ; Engels EA; Dubrow R; Crane HM; Brooks JT; Bosch RJ; Strickler HD;
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):405-13. PubMed ID: 23254153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes.
    Kreiss JK; Kiviat NB; Plummer FA; Roberts PL; Waiyaki P; Ngugi E; Holmes KK
    Sex Transm Dis; 1992; 19(1):54-9. PubMed ID: 1313992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disproportionate high incidence of invasive cervical cancer as an AIDS-indicative disease among young women in Catalonia, Spain.
    Mayans MV; Maguire A; Miret M; Casabona J
    Sex Transm Dis; 1999 Oct; 26(9):500-3. PubMed ID: 10534202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal douching in Zambia: a risk or benefit to women in the fight against cervical cancer: a retrospective cohort study.
    Hamoonga TE; Olowski P; Musonda P
    BMC Womens Health; 2019 Nov; 19(1):135. PubMed ID: 31706314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program.
    Massad LS; Seaberg EC; Watts DH; Hessol NA; Melnick S; Bitterman P; Anastos K; Silver S; Levine AM; Minkoff H
    AIDS; 2004 Jan; 18(1):109-13. PubMed ID: 15090836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.
    Zucchetto A; Ronco G; Giorgi Rossi P; Zappa M; Ferretti S; Franzo A; Falcini F; Visioli CB; Zanetti R; Biavati P; La Rosa F; Baracco S; Federico M; Campari C; De Togni A; Piffer S; Pannozzo F; Fusco M; Michiara M; Castaing M; Seghini P; Tisano F; Serraino D;
    Prev Med; 2013 Sep; 57(3):220-6. PubMed ID: 23732239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.